Filippo Gustavo Dall'Olio

10PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 13, 2026
Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung Cancer.

|May 01, 2025
Metabolic Tumor Volume and Immunotherapy in NSCLC-Reply.

Filippo Dall'Olio, Benjamin Besse, Camilo Garcia

|Nov 29, 2024
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancer.

Filippo G Dall'Olio, Wael Salem Zrafi, Quentin Blampey

|Oct 22, 2024
Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates.

Filippo G Dall'Olio, Wael Zrafi, Veronique Roelants

|Jul 08, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial.

Fabrice Barlesi, Pascale Tomasini, Maryam Karimi

|Feb 17, 2022
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC.

Filippo G Dall'Olio, Claudia Parisi, Laura Marcolin

Pageof 2

Frequent Collaborators

3 joint publications

Benjamin Besse

3 joint publications

Camilo Garcia

3 joint publications

Fabrice Barlesi

3 joint publications

Francesco Massari